U.S. Physical Therapy (USPH) Stock Price, News & Analysis

Company Overview

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.

Key Stats

• Today's Range: $70.38 to $75.11
• 50-Day Range: $64.77 to $83.06
• 52-Week Range: $62.77 to $108.14
• Volume: 117,088 shs
• Average Volume: 108,678 shs
• Market Capitalization: $1.08 billion
• P/E Ratio: 75.29
• Dividend Yield: 2.54%
• Price Target: $109.00
• Consensus Rating: Buy

U.S. Physical Therapy Stock Analysis - MarketRank™

U.S. Physical Therapy scored higher than 69% of companies evaluated by MarketBeat, and ranked 377th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

U.S. Physical Therapy has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

U.S. Physical Therapy has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 9.74%

Earnings Growth

Earnings for U.S. Physical Therapy are expected to grow by 9.74% in the coming year, from $2.67 to $2.93 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of U.S. Physical Therapy is 75.29, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.08.

Price to Earnings Ratio vs. Sector

The P/E ratio of U.S. Physical Therapy is 75.29, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.87.

Price to Earnings Growth Ratio

U.S. Physical Therapy has a PEG Ratio of 3.54. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

U.S. Physical Therapy has a P/B Ratio of 2.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.88% of the float of U.S. Physical Therapy has been sold short.

Short Interest Ratio / Days to Cover

U.S. Physical Therapy has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in U.S. Physical Therapy has recently decreased by 0.54%, indicating that investor sentiment is improving.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

U.S. Physical Therapy pays a meaningful dividend of 2.53%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

U.S. Physical Therapy does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of U.S. Physical Therapy is 97.83%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 61.43% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.88% of the float of U.S. Physical Therapy has been sold short.

Short Interest Ratio / Days to Cover

U.S. Physical Therapy has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in U.S. Physical Therapy has recently decreased by 0.54%, indicating that investor sentiment is improving.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: 0.80

News Sentiment

U.S. Physical Therapy has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.64 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for U.S. Physical Therapy this week, compared to 4 articles on an average week.

MarketBeat Follows

4 people have added U.S. Physical Therapy to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, U.S. Physical Therapy insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $142,050.00 in company stock.

Percentage Held by Insiders

Only 2.00% of the stock of U.S. Physical Therapy is held by insiders.

USPH Stock Analysis - Frequently Asked Questions

How have USPH shares performed this year?

U.S. Physical Therapy's stock was trading at $88.71 on January 1st, 2025. Since then, USPH stock has decreased by 20.2% and is now trading at $70.7760.
View the best growth stocks for 2025 here.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) issued its quarterly earnings results on Wednesday, May, 7th. The company reported $0.41 EPS for the quarter, missing analysts' consensus estimates of $0.46 by $0.05. U.S. Physical Therapy had a net margin of 3.54% and a trailing twelve-month return on equity of 8.11%.

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's top institutional shareholders include Copeland Capital Management LLC (5.37%), Boston Trust Walden Corp (3.36%), GW&K Investment Management LLC (2.27%) and Envestnet Asset Management Inc. (2.08%). Insiders that own company stock include Christopher J Reading, Carey P Hendrickson, Kathleen A Gilmartin, Bernard A Harris Jr, Richard Binstein, Eric Joseph Williams, Mark J Brookner, Harry S Chapman, Graham D Reeve, Clayton Trier, Clayton Trier, Edward L Kuntz, Anne Motsenbocker and Nancy Ham.
View institutional ownership trends.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some other companies that U.S. Physical Therapy investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), American Water Works (AWK), AUO (AUOTY) and Triple Flag Precious Metals (TFPM).

Company Calendar

• Last Earnings: 2/26/2025
• Record date for 4/11 Dividend: 3/14/2025
• Ex-Dividend for 4/11 Dividend: 3/14/2025
• Dividend Payable: 4/11/2025
• Today: 5/07/2025
• Next Earnings (Estimated): 5/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Health services
• Sub-Industry: Health Care Facilities
• Current Symbol: NYSE:USPH
• CIK: 885978
• Web: www.usph.com
• Phone: (713) 297-7000
• Fax: 713-297-7090
• Employees: 6,140
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $109.00
• High Stock Price Target: $115.00
• Low Stock Price Target: $98.00
• Potential Upside/Downside: +52.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 6 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $1.84
• Trailing P/E Ratio: 76.04
• Forward P/E Ratio: 26.77
• P/E Growth: 3.54
• Net Income: $28.24 million
• Net Margins: 3.54%
• Pretax Margin: 6.50%
• Return on Equity: 8.11%
• Return on Assets: 3.85%

Debt

• Debt-to-Equity Ratio: 0.27
• Current Ratio: 1.78
• Quick Ratio: 1.78

Sales & Book Value

• Annual Sales: $671.35 million
• Price / Sales: 1.62
• Cash Flow: $3.87 per share
• Price / Cash Flow: 18.46
• Book Value: $31.85 per share
• Price / Book: 2.24

Miscellaneous

• Outstanding Shares: 15,192,000
• Free Float: 14,838,000
• Market Cap: $1.09 billion
• Optionable: Optionable
• Beta: 1.44